NO20083091L - Dibenzen derivater som kalsiumkanalblokkere - Google Patents

Dibenzen derivater som kalsiumkanalblokkere

Info

Publication number
NO20083091L
NO20083091L NO20083091A NO20083091A NO20083091L NO 20083091 L NO20083091 L NO 20083091L NO 20083091 A NO20083091 A NO 20083091A NO 20083091 A NO20083091 A NO 20083091A NO 20083091 L NO20083091 L NO 20083091L
Authority
NO
Norway
Prior art keywords
calcium channel
channel blockers
dibenzene
derivatives
dibenzene derivatives
Prior art date
Application number
NO20083091A
Other languages
English (en)
Norwegian (no)
Inventor
Ana Castro Morera
Ana Martinez Gil
Miguel Medina Padilla
Pilar Munoz Ruiz
Laura Rubio Arrieta
Esther Garcia Palomero
Celia De Austria De Luque
Jorge Sanchez Quesada
Daniel Ignacio Perez Fernandez
Javier Lopez Ogalla
Diana Alonso Gordillo
Original Assignee
Noscira Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05077910A external-priority patent/EP1798220A1/en
Application filed by Noscira Sa filed Critical Noscira Sa
Publication of NO20083091L publication Critical patent/NO20083091L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/66—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems and singly-bound oxygen atoms, bound to the same carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20083091A 2005-12-16 2008-07-14 Dibenzen derivater som kalsiumkanalblokkere NO20083091L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05077910A EP1798220A1 (en) 2005-12-16 2005-12-16 Dibenzene derivatives as calcium channel blockers
EP06380004 2006-01-03
PCT/EP2006/069760 WO2007068754A1 (en) 2005-12-16 2006-12-15 Dibenzene derivatives as calcium channel blockers

Publications (1)

Publication Number Publication Date
NO20083091L true NO20083091L (no) 2008-08-12

Family

ID=37831482

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083091A NO20083091L (no) 2005-12-16 2008-07-14 Dibenzen derivater som kalsiumkanalblokkere

Country Status (12)

Country Link
US (1) US20090069430A1 (pt)
EP (1) EP1976823A1 (pt)
JP (1) JP2009519300A (pt)
KR (1) KR20080075922A (pt)
AU (1) AU2006325232A1 (pt)
BR (1) BRPI0619986A2 (pt)
CA (1) CA2634004A1 (pt)
MX (1) MX2008007753A (pt)
NO (1) NO20083091L (pt)
NZ (1) NZ569523A (pt)
RU (1) RU2008129098A (pt)
WO (1) WO2007068754A1 (pt)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2662913A (en) * 1952-07-11 1953-12-15 American Cyanamid Co Diaminofluorene derivatives
GB1157506A (en) * 1965-09-10 1969-07-09 Ilford Ltd Anthraquinone Dye Colour Couplers and their use in Colour Photographic Materials
US4012360A (en) * 1973-12-03 1977-03-15 Ciba-Geigy Corporation Bis-salicyloyl-dicarboxylic acid dihydrazides as stabilizers for polyolefines
CH603784A5 (pt) * 1974-05-16 1978-08-31 Ciba Geigy Ag
DE3066483D1 (en) * 1979-06-13 1984-03-15 Hoechst Ag Pharmaceutical compositions based on secretin with enhanced and protracted activity, process for their preparation and dihydroxybenzoyl-l-tyrosine
JP2722250B2 (ja) * 1989-05-30 1998-03-04 興和株式会社 新規なジアミン化合物及びこれを含有する脳機能障害改善剤
JP3486001B2 (ja) * 1995-04-28 2004-01-13 旭電化工業株式会社 感熱記録材料
JP3549613B2 (ja) * 1995-05-01 2004-08-04 旭電化工業株式会社 重金属不活性化剤
JP2006096023A (ja) * 2004-03-11 2006-04-13 Fuji Photo Film Co Ltd セルロースアシレートフィルム、その製造方法、光学補償フィルム、偏光板、及び液晶表示装置
JP2007532492A (ja) * 2004-04-09 2007-11-15 ニューロメッド ファーマシューティカルズ リミテッド カルシウムチャネルブロッカーとしてのジアリールアミン誘導体
JP2006183004A (ja) * 2004-12-28 2006-07-13 Fuji Photo Film Co Ltd セルロースアシレートフィルム、並びに、これを用いた偏光板、位相差フィルム、光学補償フィルム、反射防止フィルムおよび液晶表示装置
JP4480601B2 (ja) * 2005-02-23 2010-06-16 富士フイルム株式会社 セルロースアシレート組成物、セルロースアシレートフイルム、およびトリアルコキシ安息香酸化合物

Also Published As

Publication number Publication date
WO2007068754A1 (en) 2007-06-21
NZ569523A (en) 2011-09-30
AU2006325232A1 (en) 2007-06-21
CA2634004A1 (en) 2007-06-21
MX2008007753A (es) 2009-02-04
KR20080075922A (ko) 2008-08-19
BRPI0619986A2 (pt) 2011-10-25
EP1976823A1 (en) 2008-10-08
JP2009519300A (ja) 2009-05-14
RU2008129098A (ru) 2010-01-27
US20090069430A1 (en) 2009-03-12

Similar Documents

Publication Publication Date Title
NO20063449L (no) Substituerte heterocykler og deres anvendelse
NO20071901L (no) Substituerte bisykliske imidazo-3-ylamin sammensetninger
DK1853602T3 (da) Kemiske forbindelser
CY1108275T1 (el) Χημικες ενωσεις
NO20070489L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
ATE433447T1 (de) Pyrimiidinverbindungen
NO20082285L (no) 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer
BRPI0619153A8 (pt) derivados de 4-aminopirroltriazina substituída, e composição farmacêutica
UA97834C2 (ru) Производные сульфониламида для лечения анормального роста клеток
TW200638934A (en) Heteroaryl compounds as P2Y1 receptor inhibitors
NO20073764L (no) Sammensetninger for behandling av HCV
NO20075749L (no) 1H-Quinazoline-2,4-diones and their use as ampa-receptor ligands
NO20070487L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
EA201000329A1 (ru) Циклические депсипептиды
EA201000946A1 (ru) Бициклические производные для применения при лечении состояний, связанных с андрогенным рецептором
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
NO20083065L (no) Nye N-sulfamoylpiperidinamider for profylakse eller behandling av overvekt og beslektede tilstander
ATE494926T1 (de) Neuartige p2x7r-antagonisten und ihre verwendung
MX2011008899A (es) Nuevas orto-aminoamidas para el tratamiento del cancer.
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
NO20065678L (no) 3-(4-heteroarylcykloheksylamino) cyklopentankarboksamider som modulatorer for kjemokinreseptorer.
NO20073170L (no) Kaspaseinhibitorer og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application